nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—Amoxapine—Diazepam—epilepsy syndrome	0.0935	0.378	CrCrCtD
Asenapine—UGT1A4—Lamotrigine—epilepsy syndrome	0.0812	0.316	CbGbCtD
Asenapine—Loxapine—Clobazam—epilepsy syndrome	0.0799	0.323	CrCrCtD
Asenapine—Loxapine—Diazepam—epilepsy syndrome	0.0743	0.3	CrCrCtD
Asenapine—HTR7—epilepsy syndrome	0.0704	0.288	CbGaD
Asenapine—ADRA2A—epilepsy syndrome	0.0604	0.247	CbGaD
Asenapine—UGT1A4—Midazolam—epilepsy syndrome	0.0551	0.214	CbGbCtD
Asenapine—SLC6A4—epilepsy syndrome	0.0461	0.188	CbGaD
Asenapine—UGT1A4—Valproic Acid—epilepsy syndrome	0.0417	0.162	CbGbCtD
Asenapine—HTR2A—epilepsy syndrome	0.0354	0.145	CbGaD
Asenapine—CYP2D6—epilepsy syndrome	0.0324	0.132	CbGaD
Asenapine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00523	0.0203	CbGbCtD
Asenapine—CYP1A2—Primidone—epilepsy syndrome	0.00488	0.019	CbGbCtD
Asenapine—CYP1A2—Propofol—epilepsy syndrome	0.00437	0.017	CbGbCtD
Asenapine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00436	0.017	CbGbCtD
Asenapine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00418	0.0163	CbGbCtD
Asenapine—CYP3A4—Trimethadione—epilepsy syndrome	0.00406	0.0158	CbGbCtD
Asenapine—CYP3A4—Felbamate—epilepsy syndrome	0.00406	0.0158	CbGbCtD
Asenapine—CYP1A2—Diazepam—epilepsy syndrome	0.00396	0.0154	CbGbCtD
Asenapine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00381	0.0148	CbGbCtD
Asenapine—CYP2D6—Propofol—epilepsy syndrome	0.0036	0.014	CbGbCtD
Asenapine—CYP3A4—Clonazepam—epilepsy syndrome	0.00345	0.0134	CbGbCtD
Asenapine—HTR1D—meninx—epilepsy syndrome	0.00332	0.0683	CbGeAlD
Asenapine—CYP3A4—Clobazam—epilepsy syndrome	0.00331	0.0129	CbGbCtD
Asenapine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00312	0.0122	CbGbCtD
Asenapine—CYP3A4—Rufinamide—epilepsy syndrome	0.00281	0.0109	CbGbCtD
Asenapine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00274	0.0107	CbGbCtD
Asenapine—CYP3A4—Primidone—epilepsy syndrome	0.00256	0.00995	CbGbCtD
Asenapine—CYP3A4—Phenytoin—epilepsy syndrome	0.00246	0.00956	CbGbCtD
Asenapine—CYP3A4—Propofol—epilepsy syndrome	0.00229	0.00891	CbGbCtD
Asenapine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00219	0.00852	CbGbCtD
Asenapine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00219	0.00852	CbGbCtD
Asenapine—CYP3A4—Midazolam—epilepsy syndrome	0.00216	0.0084	CbGbCtD
Asenapine—CYP3A4—Diazepam—epilepsy syndrome	0.00208	0.00808	CbGbCtD
Asenapine—CYP3A4—Zonisamide—epilepsy syndrome	0.00203	0.00788	CbGbCtD
Asenapine—HTR2A—phrenic nerve—epilepsy syndrome	0.00178	0.0367	CbGeAlD
Asenapine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00164	0.00637	CbGbCtD
Asenapine—CYP3A4—Topiramate—epilepsy syndrome	0.00148	0.00574	CbGbCtD
Asenapine—DRD3—telencephalic ventricle—epilepsy syndrome	0.00135	0.0279	CbGeAlD
Asenapine—HTR7—locus ceruleus—epilepsy syndrome	0.00128	0.0263	CbGeAlD
Asenapine—HTR5A—forebrain—epilepsy syndrome	0.00102	0.0209	CbGeAlD
Asenapine—HTR7—vagus nerve—epilepsy syndrome	0.000978	0.0201	CbGeAlD
Asenapine—DRD1—telencephalic ventricle—epilepsy syndrome	0.00097	0.02	CbGeAlD
Asenapine—HTR6—ganglion—epilepsy syndrome	0.000811	0.0167	CbGeAlD
Asenapine—HTR2A—locus ceruleus—epilepsy syndrome	0.000797	0.0164	CbGeAlD
Asenapine—HTR1B—telencephalic ventricle—epilepsy syndrome	0.000786	0.0162	CbGeAlD
Asenapine—HTR1D—telencephalic ventricle—epilepsy syndrome	0.000761	0.0157	CbGeAlD
Asenapine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000753	0.0155	CbGeAlD
Asenapine—HTR7—pons—epilepsy syndrome	0.000736	0.0152	CbGeAlD
Asenapine—HTR7—autonomic nervous system—epilepsy syndrome	0.000679	0.014	CbGeAlD
Asenapine—HTR2A—cerebellar cortex—epilepsy syndrome	0.00065	0.0134	CbGeAlD
Asenapine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000634	0.0131	CbGeAlD
Asenapine—HTR2A—vagus nerve—epilepsy syndrome	0.00061	0.0126	CbGeAlD
Asenapine—HTR7—telencephalic ventricle—epilepsy syndrome	0.000606	0.0125	CbGeAlD
Asenapine—DRD1—ganglion—epilepsy syndrome	0.000604	0.0124	CbGeAlD
Asenapine—HTR5A—head—epilepsy syndrome	0.000582	0.012	CbGeAlD
Asenapine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000573	0.0118	CbGeAlD
Asenapine—HTR5A—nervous system—epilepsy syndrome	0.000552	0.0114	CbGeAlD
Asenapine—HTR5A—central nervous system—epilepsy syndrome	0.000531	0.0109	CbGeAlD
Asenapine—HTR1B—ganglion—epilepsy syndrome	0.000489	0.0101	CbGeAlD
Asenapine—HTR1D—ganglion—epilepsy syndrome	0.000474	0.00975	CbGeAlD
Asenapine—HTR2C—ganglion—epilepsy syndrome	0.000469	0.00966	CbGeAlD
Asenapine—HTR2A—pons—epilepsy syndrome	0.000459	0.00946	CbGeAlD
Asenapine—HTR1E—brainstem—epilepsy syndrome	0.00045	0.00926	CbGeAlD
Asenapine—SLC6A4—ganglion—epilepsy syndrome	0.000445	0.00915	CbGeAlD
Asenapine—HTR1E—forebrain—epilepsy syndrome	0.000434	0.00893	CbGeAlD
Asenapine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000423	0.00872	CbGeAlD
Asenapine—HTR5A—brain—epilepsy syndrome	0.000422	0.00868	CbGeAlD
Asenapine—HTR1E—telencephalon—epilepsy syndrome	0.000399	0.00821	CbGeAlD
Asenapine—HTR1A—ganglion—epilepsy syndrome	0.000395	0.00813	CbGeAlD
Asenapine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000378	0.00778	CbGeAlD
Asenapine—HTR7—ganglion—epilepsy syndrome	0.000377	0.00777	CbGeAlD
Asenapine—DRD2—ganglion—epilepsy syndrome	0.000357	0.00734	CbGeAlD
Asenapine—HTR6—forebrain—epilepsy syndrome	0.00034	0.00701	CbGeAlD
Asenapine—SLC6A4—hindbrain—epilepsy syndrome	0.000337	0.00694	CbGeAlD
Asenapine—HTR6—telencephalon—epilepsy syndrome	0.000313	0.00645	CbGeAlD
Asenapine—HTR1A—hindbrain—epilepsy syndrome	0.000299	0.00616	CbGeAlD
Asenapine—HTR7—hindbrain—epilepsy syndrome	0.000286	0.00589	CbGeAlD
Asenapine—ADRA1A—hindbrain—epilepsy syndrome	0.000276	0.00568	CbGeAlD
Asenapine—DRD2—hindbrain—epilepsy syndrome	0.00027	0.00557	CbGeAlD
Asenapine—DRD1—brainstem—epilepsy syndrome	0.000262	0.0054	CbGeAlD
Asenapine—DRD1—forebrain—epilepsy syndrome	0.000253	0.00521	CbGeAlD
Asenapine—HTR1E—head—epilepsy syndrome	0.000248	0.00511	CbGeAlD
Asenapine—HTR1E—nervous system—epilepsy syndrome	0.000236	0.00485	CbGeAlD
Asenapine—HTR2A—ganglion—epilepsy syndrome	0.000235	0.00484	CbGeAlD
Asenapine—DRD1—telencephalon—epilepsy syndrome	0.000233	0.00479	CbGeAlD
Asenapine—Amoxapine—GABRA1—epilepsy syndrome	0.000231	0.118	CrCbGaD
Asenapine—HTR1E—central nervous system—epilepsy syndrome	0.000227	0.00467	CbGeAlD
Asenapine—Amoxapine—CHRM1—epilepsy syndrome	0.000215	0.11	CrCbGaD
Asenapine—HTR1B—brainstem—epilepsy syndrome	0.000213	0.00438	CbGeAlD
Asenapine—DRD4—brain—epilepsy syndrome	0.000209	0.0043	CbGeAlD
Asenapine—HTR1D—brainstem—epilepsy syndrome	0.000206	0.00424	CbGeAlD
Asenapine—HTR1B—forebrain—epilepsy syndrome	0.000205	0.00423	CbGeAlD
Asenapine—HTR2C—brainstem—epilepsy syndrome	0.000204	0.0042	CbGeAlD
Asenapine—DRD3—head—epilepsy syndrome	0.000203	0.00417	CbGeAlD
Asenapine—HTR1D—forebrain—epilepsy syndrome	0.000199	0.00409	CbGeAlD
Asenapine—HTR2C—forebrain—epilepsy syndrome	0.000197	0.00405	CbGeAlD
Asenapine—HTR6—head—epilepsy syndrome	0.000195	0.00401	CbGeAlD
Asenapine—SLC6A4—brainstem—epilepsy syndrome	0.000193	0.00398	CbGeAlD
Asenapine—ADRB1—forebrain—epilepsy syndrome	0.000193	0.00397	CbGeAlD
Asenapine—DRD3—nervous system—epilepsy syndrome	0.000192	0.00395	CbGeAlD
Asenapine—HTR1B—telencephalon—epilepsy syndrome	0.000189	0.00389	CbGeAlD
Asenapine—SLC6A4—forebrain—epilepsy syndrome	0.000186	0.00384	CbGeAlD
Asenapine—DRD3—central nervous system—epilepsy syndrome	0.000185	0.00381	CbGeAlD
Asenapine—HTR6—nervous system—epilepsy syndrome	0.000185	0.00381	CbGeAlD
Asenapine—HTR2B—forebrain—epilepsy syndrome	0.000185	0.00381	CbGeAlD
Asenapine—HTR1D—telencephalon—epilepsy syndrome	0.000183	0.00376	CbGeAlD
Asenapine—HTR2C—telencephalon—epilepsy syndrome	0.000181	0.00372	CbGeAlD
Asenapine—Loxapine—CHRM3—epilepsy syndrome	0.00018	0.0924	CrCbGaD
Asenapine—HTR1E—brain—epilepsy syndrome	0.00018	0.00371	CbGeAlD
Asenapine—HTR2A—hindbrain—epilepsy syndrome	0.000178	0.00367	CbGeAlD
Asenapine—HRH2—head—epilepsy syndrome	0.000178	0.00367	CbGeAlD
Asenapine—HTR6—central nervous system—epilepsy syndrome	0.000178	0.00366	CbGeAlD
Asenapine—ADRB1—telencephalon—epilepsy syndrome	0.000178	0.00366	CbGeAlD
Asenapine—Amoxapine—HTR7—epilepsy syndrome	0.000175	0.0896	CrCbGaD
Asenapine—HTR1A—brainstem—epilepsy syndrome	0.000172	0.00353	CbGeAlD
Asenapine—SLC6A4—telencephalon—epilepsy syndrome	0.000171	0.00353	CbGeAlD
Asenapine—HTR2B—telencephalon—epilepsy syndrome	0.00017	0.0035	CbGeAlD
Asenapine—HRH2—nervous system—epilepsy syndrome	0.000169	0.00348	CbGeAlD
Asenapine—Loxapine—CHRM1—epilepsy syndrome	0.000168	0.0862	CrCbGaD
Asenapine—DRD1—midbrain—epilepsy syndrome	0.000167	0.00344	CbGeAlD
Asenapine—HTR1A—forebrain—epilepsy syndrome	0.000166	0.00341	CbGeAlD
Asenapine—HTR7—brainstem—epilepsy syndrome	0.000164	0.00338	CbGeAlD
Asenapine—HRH2—central nervous system—epilepsy syndrome	0.000163	0.00335	CbGeAlD
Asenapine—CYP2D6—hindbrain—epilepsy syndrome	0.000163	0.00335	CbGeAlD
Asenapine—HTR7—forebrain—epilepsy syndrome	0.000158	0.00326	CbGeAlD
Asenapine—ADRA1A—brainstem—epilepsy syndrome	0.000158	0.00326	CbGeAlD
Asenapine—DRD2—brainstem—epilepsy syndrome	0.000155	0.00319	CbGeAlD
Asenapine—ADRA1A—forebrain—epilepsy syndrome	0.000153	0.00314	CbGeAlD
Asenapine—HTR1A—telencephalon—epilepsy syndrome	0.000152	0.00314	CbGeAlD
Asenapine—Amoxapine—ADRA2A—epilepsy syndrome	0.00015	0.0769	CrCbGaD
Asenapine—DRD2—forebrain—epilepsy syndrome	0.00015	0.00308	CbGeAlD
Asenapine—DRD3—brain—epilepsy syndrome	0.000147	0.00302	CbGeAlD
Asenapine—HTR7—telencephalon—epilepsy syndrome	0.000146	0.003	CbGeAlD
Asenapine—DRD1—head—epilepsy syndrome	0.000145	0.00299	CbGeAlD
Asenapine—HTR2C—medulla oblongata—epilepsy syndrome	0.000142	0.00293	CbGeAlD
Asenapine—HTR6—brain—epilepsy syndrome	0.000141	0.00291	CbGeAlD
Asenapine—ADRA1A—telencephalon—epilepsy syndrome	0.00014	0.00289	CbGeAlD
Asenapine—DRD2—telencephalon—epilepsy syndrome	0.000138	0.00283	CbGeAlD
Asenapine—DRD1—nervous system—epilepsy syndrome	0.000137	0.00283	CbGeAlD
Asenapine—Loxapine—CHRM2—epilepsy syndrome	0.000137	0.0703	CrCbGaD
Asenapine—Loxapine—HTR7—epilepsy syndrome	0.000136	0.07	CrCbGaD
Asenapine—HTR1B—midbrain—epilepsy syndrome	0.000135	0.00279	CbGeAlD
Asenapine—ADRA2C—telencephalon—epilepsy syndrome	0.000134	0.00275	CbGeAlD
Asenapine—DRD1—central nervous system—epilepsy syndrome	0.000132	0.00273	CbGeAlD
Asenapine—HTR1B—spinal cord—epilepsy syndrome	0.000132	0.00272	CbGeAlD
Asenapine—HTR1D—midbrain—epilepsy syndrome	0.000131	0.0027	CbGeAlD
Asenapine—HTR2C—midbrain—epilepsy syndrome	0.00013	0.00267	CbGeAlD
Asenapine—HRH2—brain—epilepsy syndrome	0.000129	0.00266	CbGeAlD
Asenapine—HTR2C—spinal cord—epilepsy syndrome	0.000127	0.00261	CbGeAlD
Asenapine—SLC6A4—midbrain—epilepsy syndrome	0.000123	0.00254	CbGeAlD
Asenapine—SLC6A4—spinal cord—epilepsy syndrome	0.00012	0.00247	CbGeAlD
Asenapine—HRH1—forebrain—epilepsy syndrome	0.000118	0.00243	CbGeAlD
Asenapine—HTR1B—head—epilepsy syndrome	0.000117	0.00242	CbGeAlD
Asenapine—Loxapine—ADRA2A—epilepsy syndrome	0.000117	0.06	CrCbGaD
Asenapine—ADRA2A—forebrain—epilepsy syndrome	0.000116	0.00239	CbGeAlD
Asenapine—HTR7—medulla oblongata—epilepsy syndrome	0.000114	0.00235	CbGeAlD
Asenapine—Amoxapine—SLC6A4—epilepsy syndrome	0.000114	0.0586	CrCbGaD
Asenapine—HTR1D—head—epilepsy syndrome	0.000114	0.00234	CbGeAlD
Asenapine—HTR2C—head—epilepsy syndrome	0.000113	0.00232	CbGeAlD
Asenapine—HTR1B—nervous system—epilepsy syndrome	0.000111	0.00229	CbGeAlD
Asenapine—ADRB1—head—epilepsy syndrome	0.000111	0.00228	CbGeAlD
Asenapine—HTR1A—midbrain—epilepsy syndrome	0.000109	0.00225	CbGeAlD
Asenapine—HRH1—telencephalon—epilepsy syndrome	0.000109	0.00224	CbGeAlD
Asenapine—HTR1D—nervous system—epilepsy syndrome	0.000108	0.00222	CbGeAlD
Asenapine—HTR1B—central nervous system—epilepsy syndrome	0.000107	0.00221	CbGeAlD
Asenapine—HTR2C—nervous system—epilepsy syndrome	0.000107	0.0022	CbGeAlD
Asenapine—SLC6A4—head—epilepsy syndrome	0.000107	0.0022	CbGeAlD
Asenapine—ADRA2A—telencephalon—epilepsy syndrome	0.000107	0.0022	CbGeAlD
Asenapine—HTR1A—spinal cord—epilepsy syndrome	0.000107	0.0022	CbGeAlD
Asenapine—HTR2B—head—epilepsy syndrome	0.000106	0.00218	CbGeAlD
Asenapine—ADRA2C—medulla oblongata—epilepsy syndrome	0.000105	0.00216	CbGeAlD
Asenapine—DRD1—brain—epilepsy syndrome	0.000105	0.00216	CbGeAlD
Asenapine—ADRB1—nervous system—epilepsy syndrome	0.000105	0.00216	CbGeAlD
Asenapine—HTR7—midbrain—epilepsy syndrome	0.000104	0.00215	CbGeAlD
Asenapine—HTR1D—central nervous system—epilepsy syndrome	0.000104	0.00214	CbGeAlD
Asenapine—HTR2C—central nervous system—epilepsy syndrome	0.000103	0.00212	CbGeAlD
Asenapine—HTR2A—brainstem—epilepsy syndrome	0.000102	0.00211	CbGeAlD
Asenapine—HTR7—spinal cord—epilepsy syndrome	0.000102	0.0021	CbGeAlD
Asenapine—SLC6A4—nervous system—epilepsy syndrome	0.000101	0.00208	CbGeAlD
Asenapine—ADRB1—central nervous system—epilepsy syndrome	0.000101	0.00208	CbGeAlD
Asenapine—HTR2B—nervous system—epilepsy syndrome	0.0001	0.00207	CbGeAlD
Asenapine—DRD2—midbrain—epilepsy syndrome	9.88e-05	0.00203	CbGeAlD
Asenapine—HTR2A—forebrain—epilepsy syndrome	9.87e-05	0.00203	CbGeAlD
Asenapine—SLC6A4—central nervous system—epilepsy syndrome	9.75e-05	0.00201	CbGeAlD
Asenapine—HTR2B—central nervous system—epilepsy syndrome	9.66e-05	0.00199	CbGeAlD
Asenapine—ADRA2C—midbrain—epilepsy syndrome	9.6e-05	0.00198	CbGeAlD
Asenapine—HTR1A—head—epilepsy syndrome	9.48e-05	0.00195	CbGeAlD
Asenapine—ADRA2C—spinal cord—epilepsy syndrome	9.37e-05	0.00193	CbGeAlD
Asenapine—CYP2D6—brainstem—epilepsy syndrome	9.31e-05	0.00192	CbGeAlD
Asenapine—HTR2A—telencephalon—epilepsy syndrome	9.07e-05	0.00187	CbGeAlD
Asenapine—HTR7—head—epilepsy syndrome	9.06e-05	0.00187	CbGeAlD
Asenapine—CYP2D6—forebrain—epilepsy syndrome	8.99e-05	0.00185	CbGeAlD
Asenapine—HTR1A—nervous system—epilepsy syndrome	8.99e-05	0.00185	CbGeAlD
Asenapine—Loxapine—SLC6A4—epilepsy syndrome	8.93e-05	0.0458	CrCbGaD
Asenapine—Amoxapine—HTR2A—epilepsy syndrome	8.79e-05	0.0451	CrCbGaD
Asenapine—ADRA1A—head—epilepsy syndrome	8.74e-05	0.0018	CbGeAlD
Asenapine—HTR1A—central nervous system—epilepsy syndrome	8.65e-05	0.00178	CbGeAlD
Asenapine—HTR7—nervous system—epilepsy syndrome	8.59e-05	0.00177	CbGeAlD
Asenapine—DRD2—head—epilepsy syndrome	8.57e-05	0.00176	CbGeAlD
Asenapine—HTR1B—brain—epilepsy syndrome	8.51e-05	0.00175	CbGeAlD
Asenapine—HTR1A—cerebellum—epilepsy syndrome	8.46e-05	0.00174	CbGeAlD
Asenapine—ADRA2A—medulla oblongata—epilepsy syndrome	8.39e-05	0.00173	CbGeAlD
Asenapine—ADRA2C—head—epilepsy syndrome	8.33e-05	0.00171	CbGeAlD
Asenapine—ADRA1A—nervous system—epilepsy syndrome	8.29e-05	0.00171	CbGeAlD
Asenapine—HTR7—central nervous system—epilepsy syndrome	8.27e-05	0.0017	CbGeAlD
Asenapine—CYP2D6—telencephalon—epilepsy syndrome	8.27e-05	0.0017	CbGeAlD
Asenapine—HTR1D—brain—epilepsy syndrome	8.24e-05	0.0017	CbGeAlD
Asenapine—HTR2C—brain—epilepsy syndrome	8.16e-05	0.00168	CbGeAlD
Asenapine—DRD2—nervous system—epilepsy syndrome	8.12e-05	0.00167	CbGeAlD
Asenapine—HTR7—cerebellum—epilepsy syndrome	8.08e-05	0.00166	CbGeAlD
Asenapine—Amoxapine—CYP2D6—epilepsy syndrome	8.04e-05	0.0412	CrCbGaD
Asenapine—ADRB1—brain—epilepsy syndrome	8.01e-05	0.00165	CbGeAlD
Asenapine—ADRA1A—central nervous system—epilepsy syndrome	7.98e-05	0.00164	CbGeAlD
Asenapine—ADRA2C—nervous system—epilepsy syndrome	7.9e-05	0.00163	CbGeAlD
Asenapine—DRD2—central nervous system—epilepsy syndrome	7.82e-05	0.00161	CbGeAlD
Asenapine—ADRA1A—cerebellum—epilepsy syndrome	7.8e-05	0.00161	CbGeAlD
Asenapine—SLC6A4—brain—epilepsy syndrome	7.74e-05	0.00159	CbGeAlD
Asenapine—HTR2B—brain—epilepsy syndrome	7.67e-05	0.00158	CbGeAlD
Asenapine—ADRA2A—midbrain—epilepsy syndrome	7.66e-05	0.00158	CbGeAlD
Asenapine—DRD2—cerebellum—epilepsy syndrome	7.64e-05	0.00157	CbGeAlD
Asenapine—ADRA2C—central nervous system—epilepsy syndrome	7.6e-05	0.00157	CbGeAlD
Asenapine—ADRA2A—spinal cord—epilepsy syndrome	7.48e-05	0.00154	CbGeAlD
Asenapine—ADRA2C—cerebellum—epilepsy syndrome	7.43e-05	0.00153	CbGeAlD
Asenapine—HTR2A—medulla oblongata—epilepsy syndrome	7.13e-05	0.00147	CbGeAlD
Asenapine—HTR1A—brain—epilepsy syndrome	6.87e-05	0.00141	CbGeAlD
Asenapine—Loxapine—HTR2A—epilepsy syndrome	6.86e-05	0.0352	CrCbGaD
Asenapine—HRH1—head—epilepsy syndrome	6.77e-05	0.00139	CbGeAlD
Asenapine—ADRA2A—head—epilepsy syndrome	6.65e-05	0.00137	CbGeAlD
Asenapine—HTR7—brain—epilepsy syndrome	6.57e-05	0.00135	CbGeAlD
Asenapine—HTR2A—midbrain—epilepsy syndrome	6.52e-05	0.00134	CbGeAlD
Asenapine—HRH1—nervous system—epilepsy syndrome	6.41e-05	0.00132	CbGeAlD
Asenapine—HTR2A—spinal cord—epilepsy syndrome	6.36e-05	0.00131	CbGeAlD
Asenapine—ADRA1A—brain—epilepsy syndrome	6.33e-05	0.0013	CbGeAlD
Asenapine—ADRA2A—nervous system—epilepsy syndrome	6.3e-05	0.0013	CbGeAlD
Asenapine—DRD2—brain—epilepsy syndrome	6.21e-05	0.00128	CbGeAlD
Asenapine—HRH1—central nervous system—epilepsy syndrome	6.18e-05	0.00127	CbGeAlD
Asenapine—ADRA2A—central nervous system—epilepsy syndrome	6.07e-05	0.00125	CbGeAlD
Asenapine—ADRA2C—brain—epilepsy syndrome	6.04e-05	0.00124	CbGeAlD
Asenapine—ADRA2A—cerebellum—epilepsy syndrome	5.93e-05	0.00122	CbGeAlD
Asenapine—HTR2A—head—epilepsy syndrome	5.65e-05	0.00116	CbGeAlD
Asenapine—HTR2A—nervous system—epilepsy syndrome	5.36e-05	0.0011	CbGeAlD
Asenapine—HTR2A—central nervous system—epilepsy syndrome	5.16e-05	0.00106	CbGeAlD
Asenapine—CYP2D6—head—epilepsy syndrome	5.15e-05	0.00106	CbGeAlD
Asenapine—HTR2A—cerebellum—epilepsy syndrome	5.04e-05	0.00104	CbGeAlD
Asenapine—CYP3A4—nervous system—epilepsy syndrome	4.96e-05	0.00102	CbGeAlD
Asenapine—HRH1—brain—epilepsy syndrome	4.9e-05	0.00101	CbGeAlD
Asenapine—CYP2D6—nervous system—epilepsy syndrome	4.88e-05	0.001	CbGeAlD
Asenapine—ADRA2A—brain—epilepsy syndrome	4.82e-05	0.000992	CbGeAlD
Asenapine—CYP3A4—central nervous system—epilepsy syndrome	4.77e-05	0.000983	CbGeAlD
Asenapine—CYP2D6—central nervous system—epilepsy syndrome	4.7e-05	0.000967	CbGeAlD
Asenapine—CYP2D6—cerebellum—epilepsy syndrome	4.59e-05	0.000946	CbGeAlD
Asenapine—Hyperglycaemia—Topiramate—epilepsy syndrome	4.36e-05	0.000388	CcSEcCtD
Asenapine—Malaise—Valproic Acid—epilepsy syndrome	4.36e-05	0.000388	CcSEcCtD
Asenapine—Leukopenia—Valproic Acid—epilepsy syndrome	4.33e-05	0.000385	CcSEcCtD
Asenapine—Asthenia—Vigabatrin—epilepsy syndrome	4.32e-05	0.000384	CcSEcCtD
Asenapine—Eye disorder—Gabapentin—epilepsy syndrome	4.3e-05	0.000382	CcSEcCtD
Asenapine—Depression—Topiramate—epilepsy syndrome	4.3e-05	0.000382	CcSEcCtD
Asenapine—Dizziness—Midazolam—epilepsy syndrome	4.29e-05	0.000381	CcSEcCtD
Asenapine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	4.29e-05	0.000381	CcSEcCtD
Asenapine—Fatigue—Lamotrigine—epilepsy syndrome	4.28e-05	0.000381	CcSEcCtD
Asenapine—Dysgeusia—Pregabalin—epilepsy syndrome	4.28e-05	0.00038	CcSEcCtD
Asenapine—Cardiac disorder—Gabapentin—epilepsy syndrome	4.27e-05	0.00038	CcSEcCtD
Asenapine—Asthenia—Diazepam—epilepsy syndrome	4.26e-05	0.000379	CcSEcCtD
Asenapine—Constipation—Lamotrigine—epilepsy syndrome	4.24e-05	0.000377	CcSEcCtD
Asenapine—Nausea—Acetazolamide—epilepsy syndrome	4.24e-05	0.000377	CcSEcCtD
Asenapine—Dizziness—Levetiracetam—epilepsy syndrome	4.24e-05	0.000377	CcSEcCtD
Asenapine—Vomiting—Propofol—epilepsy syndrome	4.22e-05	0.000375	CcSEcCtD
Asenapine—Stomatitis—Topiramate—epilepsy syndrome	4.2e-05	0.000374	CcSEcCtD
Asenapine—Muscle spasms—Pregabalin—epilepsy syndrome	4.2e-05	0.000374	CcSEcCtD
Asenapine—Rash—Propofol—epilepsy syndrome	4.18e-05	0.000372	CcSEcCtD
Asenapine—Dermatitis—Propofol—epilepsy syndrome	4.18e-05	0.000371	CcSEcCtD
Asenapine—Hypertension—Valproic Acid—epilepsy syndrome	4.17e-05	0.000371	CcSEcCtD
Asenapine—Immune system disorder—Gabapentin—epilepsy syndrome	4.16e-05	0.00037	CcSEcCtD
Asenapine—Headache—Propofol—epilepsy syndrome	4.15e-05	0.000369	CcSEcCtD
Asenapine—Mediastinal disorder—Gabapentin—epilepsy syndrome	4.15e-05	0.000369	CcSEcCtD
Asenapine—Hypersensitivity—Zonisamide—epilepsy syndrome	4.14e-05	0.000368	CcSEcCtD
Asenapine—Vomiting—Midazolam—epilepsy syndrome	4.12e-05	0.000367	CcSEcCtD
Asenapine—Asthenia—Felbamate—epilepsy syndrome	4.12e-05	0.000366	CcSEcCtD
Asenapine—Arthralgia—Valproic Acid—epilepsy syndrome	4.11e-05	0.000366	CcSEcCtD
Asenapine—Anxiety—Valproic Acid—epilepsy syndrome	4.1e-05	0.000365	CcSEcCtD
Asenapine—HTR2A—brain—epilepsy syndrome	4.09e-05	0.000843	CbGeAlD
Asenapine—Tremor—Pregabalin—epilepsy syndrome	4.09e-05	0.000364	CcSEcCtD
Asenapine—Rash—Midazolam—epilepsy syndrome	4.09e-05	0.000364	CcSEcCtD
Asenapine—Dizziness—Fosphenytoin—epilepsy syndrome	4.09e-05	0.000364	CcSEcCtD
Asenapine—Dermatitis—Midazolam—epilepsy syndrome	4.09e-05	0.000363	CcSEcCtD
Asenapine—Vomiting—Levetiracetam—epilepsy syndrome	4.07e-05	0.000362	CcSEcCtD
Asenapine—Headache—Midazolam—epilepsy syndrome	4.06e-05	0.000361	CcSEcCtD
Asenapine—Rash—Levetiracetam—epilepsy syndrome	4.04e-05	0.000359	CcSEcCtD
Asenapine—Anaemia—Pregabalin—epilepsy syndrome	4.04e-05	0.000359	CcSEcCtD
Asenapine—Dermatitis—Levetiracetam—epilepsy syndrome	4.03e-05	0.000359	CcSEcCtD
Asenapine—Asthenia—Zonisamide—epilepsy syndrome	4.03e-05	0.000359	CcSEcCtD
Asenapine—Mental disorder—Gabapentin—epilepsy syndrome	4.03e-05	0.000359	CcSEcCtD
Asenapine—Agranulocytosis—Topiramate—epilepsy syndrome	4.02e-05	0.000358	CcSEcCtD
Asenapine—Dry mouth—Valproic Acid—epilepsy syndrome	4.02e-05	0.000358	CcSEcCtD
Asenapine—Agitation—Pregabalin—epilepsy syndrome	4.01e-05	0.000357	CcSEcCtD
Asenapine—Headache—Levetiracetam—epilepsy syndrome	4.01e-05	0.000357	CcSEcCtD
Asenapine—Malnutrition—Gabapentin—epilepsy syndrome	4.01e-05	0.000356	CcSEcCtD
Asenapine—Angioedema—Pregabalin—epilepsy syndrome	3.99e-05	0.000355	CcSEcCtD
Asenapine—Hypersensitivity—Clonazepam—epilepsy syndrome	3.99e-05	0.000355	CcSEcCtD
Asenapine—Dizziness—Vigabatrin—epilepsy syndrome	3.98e-05	0.000354	CcSEcCtD
Asenapine—Hypersensitivity—Phenytoin—epilepsy syndrome	3.96e-05	0.000353	CcSEcCtD
Asenapine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.94e-05	0.000351	CcSEcCtD
Asenapine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.94e-05	0.000351	CcSEcCtD
Asenapine—Malaise—Pregabalin—epilepsy syndrome	3.94e-05	0.00035	CcSEcCtD
Asenapine—Nausea—Propofol—epilepsy syndrome	3.94e-05	0.00035	CcSEcCtD
Asenapine—Vomiting—Fosphenytoin—epilepsy syndrome	3.93e-05	0.00035	CcSEcCtD
Asenapine—Dysgeusia—Gabapentin—epilepsy syndrome	3.92e-05	0.000349	CcSEcCtD
Asenapine—Dizziness—Diazepam—epilepsy syndrome	3.92e-05	0.000349	CcSEcCtD
Asenapine—Syncope—Pregabalin—epilepsy syndrome	3.92e-05	0.000348	CcSEcCtD
Asenapine—Leukopenia—Pregabalin—epilepsy syndrome	3.91e-05	0.000348	CcSEcCtD
Asenapine—Rash—Fosphenytoin—epilepsy syndrome	3.9e-05	0.000347	CcSEcCtD
Asenapine—Dermatitis—Fosphenytoin—epilepsy syndrome	3.89e-05	0.000346	CcSEcCtD
Asenapine—Asthenia—Clonazepam—epilepsy syndrome	3.89e-05	0.000346	CcSEcCtD
Asenapine—Headache—Fosphenytoin—epilepsy syndrome	3.87e-05	0.000344	CcSEcCtD
Asenapine—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.87e-05	0.000344	CcSEcCtD
Asenapine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.86e-05	0.000343	CcSEcCtD
Asenapine—Asthenia—Phenytoin—epilepsy syndrome	3.86e-05	0.000343	CcSEcCtD
Asenapine—Nausea—Midazolam—epilepsy syndrome	3.85e-05	0.000343	CcSEcCtD
Asenapine—Muscle spasms—Gabapentin—epilepsy syndrome	3.85e-05	0.000343	CcSEcCtD
Asenapine—Tachycardia—Valproic Acid—epilepsy syndrome	3.85e-05	0.000342	CcSEcCtD
Asenapine—Loss of consciousness—Pregabalin—epilepsy syndrome	3.84e-05	0.000341	CcSEcCtD
Asenapine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.84e-05	0.000341	CcSEcCtD
Asenapine—Vomiting—Vigabatrin—epilepsy syndrome	3.83e-05	0.000341	CcSEcCtD
Asenapine—Oedema peripheral—Topiramate—epilepsy syndrome	3.81e-05	0.000339	CcSEcCtD
Asenapine—Connective tissue disorder—Topiramate—epilepsy syndrome	3.8e-05	0.000338	CcSEcCtD
Asenapine—Nausea—Levetiracetam—epilepsy syndrome	3.8e-05	0.000338	CcSEcCtD
Asenapine—Rash—Vigabatrin—epilepsy syndrome	3.8e-05	0.000338	CcSEcCtD
Asenapine—Dizziness—Felbamate—epilepsy syndrome	3.8e-05	0.000338	CcSEcCtD
Asenapine—Dermatitis—Vigabatrin—epilepsy syndrome	3.8e-05	0.000338	CcSEcCtD
Asenapine—Convulsion—Pregabalin—epilepsy syndrome	3.79e-05	0.000337	CcSEcCtD
Asenapine—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.78e-05	0.000336	CcSEcCtD
Asenapine—Headache—Vigabatrin—epilepsy syndrome	3.77e-05	0.000336	CcSEcCtD
Asenapine—Hypertension—Pregabalin—epilepsy syndrome	3.77e-05	0.000335	CcSEcCtD
Asenapine—Vomiting—Diazepam—epilepsy syndrome	3.77e-05	0.000335	CcSEcCtD
Asenapine—Tremor—Gabapentin—epilepsy syndrome	3.75e-05	0.000334	CcSEcCtD
Asenapine—Rash—Diazepam—epilepsy syndrome	3.74e-05	0.000333	CcSEcCtD
Asenapine—Dermatitis—Diazepam—epilepsy syndrome	3.74e-05	0.000332	CcSEcCtD
Asenapine—CYP2D6—brain—epilepsy syndrome	3.73e-05	0.000768	CbGeAlD
Asenapine—Arthralgia—Pregabalin—epilepsy syndrome	3.72e-05	0.000331	CcSEcCtD
Asenapine—Dizziness—Zonisamide—epilepsy syndrome	3.72e-05	0.000331	CcSEcCtD
Asenapine—Headache—Diazepam—epilepsy syndrome	3.72e-05	0.000331	CcSEcCtD
Asenapine—Anxiety—Pregabalin—epilepsy syndrome	3.71e-05	0.00033	CcSEcCtD
Asenapine—Anaemia—Gabapentin—epilepsy syndrome	3.7e-05	0.000329	CcSEcCtD
Asenapine—Hypotension—Valproic Acid—epilepsy syndrome	3.69e-05	0.000328	CcSEcCtD
Asenapine—Asthenia—Carbamazepine—epilepsy syndrome	3.68e-05	0.000328	CcSEcCtD
Asenapine—Agitation—Gabapentin—epilepsy syndrome	3.68e-05	0.000327	CcSEcCtD
Asenapine—Nausea—Fosphenytoin—epilepsy syndrome	3.67e-05	0.000327	CcSEcCtD
Asenapine—Angioedema—Gabapentin—epilepsy syndrome	3.66e-05	0.000326	CcSEcCtD
Asenapine—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.66e-05	0.000325	CcSEcCtD
Asenapine—Vomiting—Felbamate—epilepsy syndrome	3.65e-05	0.000325	CcSEcCtD
Asenapine—Dry mouth—Pregabalin—epilepsy syndrome	3.64e-05	0.000324	CcSEcCtD
Asenapine—Rash—Felbamate—epilepsy syndrome	3.62e-05	0.000322	CcSEcCtD
Asenapine—Eye disorder—Topiramate—epilepsy syndrome	3.62e-05	0.000322	CcSEcCtD
Asenapine—Dermatitis—Felbamate—epilepsy syndrome	3.62e-05	0.000322	CcSEcCtD
Asenapine—Malaise—Gabapentin—epilepsy syndrome	3.61e-05	0.000321	CcSEcCtD
Asenapine—Headache—Felbamate—epilepsy syndrome	3.6e-05	0.00032	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.59e-05	0.00032	CcSEcCtD
Asenapine—Cardiac disorder—Topiramate—epilepsy syndrome	3.59e-05	0.00032	CcSEcCtD
Asenapine—Syncope—Gabapentin—epilepsy syndrome	3.59e-05	0.00032	CcSEcCtD
Asenapine—Leukopenia—Gabapentin—epilepsy syndrome	3.59e-05	0.000319	CcSEcCtD
Asenapine—Dizziness—Clonazepam—epilepsy syndrome	3.58e-05	0.000319	CcSEcCtD
Asenapine—Nausea—Vigabatrin—epilepsy syndrome	3.58e-05	0.000318	CcSEcCtD
Asenapine—Vomiting—Zonisamide—epilepsy syndrome	3.57e-05	0.000318	CcSEcCtD
Asenapine—Insomnia—Valproic Acid—epilepsy syndrome	3.57e-05	0.000317	CcSEcCtD
Asenapine—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.57e-05	0.000317	CcSEcCtD
Asenapine—Asthenia—Lamotrigine—epilepsy syndrome	3.56e-05	0.000317	CcSEcCtD
Asenapine—Dizziness—Phenytoin—epilepsy syndrome	3.56e-05	0.000316	CcSEcCtD
Asenapine—Rash—Zonisamide—epilepsy syndrome	3.54e-05	0.000315	CcSEcCtD
Asenapine—Dermatitis—Zonisamide—epilepsy syndrome	3.54e-05	0.000315	CcSEcCtD
Asenapine—Dizziness—Oxcarbazepine—epilepsy syndrome	3.54e-05	0.000315	CcSEcCtD
Asenapine—Nausea—Diazepam—epilepsy syndrome	3.52e-05	0.000313	CcSEcCtD
Asenapine—Loss of consciousness—Gabapentin—epilepsy syndrome	3.52e-05	0.000313	CcSEcCtD
Asenapine—Headache—Zonisamide—epilepsy syndrome	3.52e-05	0.000313	CcSEcCtD
Asenapine—Dyspnoea—Valproic Acid—epilepsy syndrome	3.52e-05	0.000313	CcSEcCtD
Asenapine—Angiopathy—Topiramate—epilepsy syndrome	3.51e-05	0.000312	CcSEcCtD
Asenapine—Shock—Pregabalin—epilepsy syndrome	3.51e-05	0.000312	CcSEcCtD
Asenapine—Somnolence—Valproic Acid—epilepsy syndrome	3.51e-05	0.000312	CcSEcCtD
Asenapine—Immune system disorder—Topiramate—epilepsy syndrome	3.5e-05	0.000311	CcSEcCtD
Asenapine—Nervous system disorder—Pregabalin—epilepsy syndrome	3.5e-05	0.000311	CcSEcCtD
Asenapine—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.49e-05	0.00031	CcSEcCtD
Asenapine—Mediastinal disorder—Topiramate—epilepsy syndrome	3.49e-05	0.00031	CcSEcCtD
Asenapine—Tachycardia—Pregabalin—epilepsy syndrome	3.48e-05	0.000309	CcSEcCtD
Asenapine—Dyspepsia—Valproic Acid—epilepsy syndrome	3.47e-05	0.000309	CcSEcCtD
Asenapine—Convulsion—Gabapentin—epilepsy syndrome	3.47e-05	0.000309	CcSEcCtD
Asenapine—Hypertension—Gabapentin—epilepsy syndrome	3.46e-05	0.000308	CcSEcCtD
Asenapine—Vomiting—Clonazepam—epilepsy syndrome	3.44e-05	0.000306	CcSEcCtD
Asenapine—Vomiting—Phenytoin—epilepsy syndrome	3.42e-05	0.000304	CcSEcCtD
Asenapine—Rash—Clonazepam—epilepsy syndrome	3.42e-05	0.000304	CcSEcCtD
Asenapine—Dermatitis—Clonazepam—epilepsy syndrome	3.41e-05	0.000303	CcSEcCtD
Asenapine—Arthralgia—Gabapentin—epilepsy syndrome	3.41e-05	0.000303	CcSEcCtD
Asenapine—Nausea—Felbamate—epilepsy syndrome	3.41e-05	0.000303	CcSEcCtD
Asenapine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.41e-05	0.000303	CcSEcCtD
Asenapine—Vomiting—Oxcarbazepine—epilepsy syndrome	3.4e-05	0.000303	CcSEcCtD
Asenapine—Fatigue—Valproic Acid—epilepsy syndrome	3.4e-05	0.000302	CcSEcCtD
Asenapine—Anxiety—Gabapentin—epilepsy syndrome	3.4e-05	0.000302	CcSEcCtD
Asenapine—Dizziness—Carbamazepine—epilepsy syndrome	3.4e-05	0.000302	CcSEcCtD
Asenapine—Headache—Clonazepam—epilepsy syndrome	3.39e-05	0.000302	CcSEcCtD
Asenapine—Rash—Phenytoin—epilepsy syndrome	3.39e-05	0.000302	CcSEcCtD
Asenapine—Mental disorder—Topiramate—epilepsy syndrome	3.39e-05	0.000302	CcSEcCtD
Asenapine—Dermatitis—Phenytoin—epilepsy syndrome	3.39e-05	0.000301	CcSEcCtD
Asenapine—Rash—Oxcarbazepine—epilepsy syndrome	3.37e-05	0.0003	CcSEcCtD
Asenapine—Constipation—Valproic Acid—epilepsy syndrome	3.37e-05	0.0003	CcSEcCtD
Asenapine—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.37e-05	0.0003	CcSEcCtD
Asenapine—Headache—Phenytoin—epilepsy syndrome	3.37e-05	0.0003	CcSEcCtD
Asenapine—Malnutrition—Topiramate—epilepsy syndrome	3.37e-05	0.0003	CcSEcCtD
Asenapine—Headache—Oxcarbazepine—epilepsy syndrome	3.35e-05	0.000298	CcSEcCtD
Asenapine—Nausea—Zonisamide—epilepsy syndrome	3.34e-05	0.000297	CcSEcCtD
Asenapine—Dry mouth—Gabapentin—epilepsy syndrome	3.34e-05	0.000297	CcSEcCtD
Asenapine—Hypotension—Pregabalin—epilepsy syndrome	3.33e-05	0.000296	CcSEcCtD
Asenapine—Dysgeusia—Topiramate—epilepsy syndrome	3.3e-05	0.000294	CcSEcCtD
Asenapine—Dizziness—Lamotrigine—epilepsy syndrome	3.28e-05	0.000292	CcSEcCtD
Asenapine—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.27e-05	0.000291	CcSEcCtD
Asenapine—Vomiting—Carbamazepine—epilepsy syndrome	3.27e-05	0.00029	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.25e-05	0.000289	CcSEcCtD
Asenapine—Muscle spasms—Topiramate—epilepsy syndrome	3.24e-05	0.000288	CcSEcCtD
Asenapine—Rash—Carbamazepine—epilepsy syndrome	3.24e-05	0.000288	CcSEcCtD
Asenapine—Dermatitis—Carbamazepine—epilepsy syndrome	3.24e-05	0.000288	CcSEcCtD
Asenapine—Insomnia—Pregabalin—epilepsy syndrome	3.22e-05	0.000287	CcSEcCtD
Asenapine—Nausea—Clonazepam—epilepsy syndrome	3.22e-05	0.000286	CcSEcCtD
Asenapine—Headache—Carbamazepine—epilepsy syndrome	3.22e-05	0.000286	CcSEcCtD
Asenapine—Shock—Gabapentin—epilepsy syndrome	3.22e-05	0.000286	CcSEcCtD
Asenapine—Nervous system disorder—Gabapentin—epilepsy syndrome	3.21e-05	0.000285	CcSEcCtD
Asenapine—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.2e-05	0.000285	CcSEcCtD
Asenapine—Nausea—Phenytoin—epilepsy syndrome	3.2e-05	0.000284	CcSEcCtD
Asenapine—Tachycardia—Gabapentin—epilepsy syndrome	3.19e-05	0.000284	CcSEcCtD
Asenapine—Dyspnoea—Pregabalin—epilepsy syndrome	3.18e-05	0.000283	CcSEcCtD
Asenapine—Nausea—Oxcarbazepine—epilepsy syndrome	3.18e-05	0.000283	CcSEcCtD
Asenapine—Somnolence—Pregabalin—epilepsy syndrome	3.17e-05	0.000282	CcSEcCtD
Asenapine—Tremor—Topiramate—epilepsy syndrome	3.16e-05	0.000281	CcSEcCtD
Asenapine—Vomiting—Lamotrigine—epilepsy syndrome	3.16e-05	0.000281	CcSEcCtD
Asenapine—Rash—Lamotrigine—epilepsy syndrome	3.13e-05	0.000278	CcSEcCtD
Asenapine—Dermatitis—Lamotrigine—epilepsy syndrome	3.13e-05	0.000278	CcSEcCtD
Asenapine—Anaemia—Topiramate—epilepsy syndrome	3.12e-05	0.000277	CcSEcCtD
Asenapine—Headache—Lamotrigine—epilepsy syndrome	3.11e-05	0.000277	CcSEcCtD
Asenapine—Agitation—Topiramate—epilepsy syndrome	3.1e-05	0.000275	CcSEcCtD
Asenapine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.08e-05	0.000274	CcSEcCtD
Asenapine—Fatigue—Pregabalin—epilepsy syndrome	3.07e-05	0.000273	CcSEcCtD
Asenapine—Hypotension—Gabapentin—epilepsy syndrome	3.06e-05	0.000272	CcSEcCtD
Asenapine—Nausea—Carbamazepine—epilepsy syndrome	3.05e-05	0.000271	CcSEcCtD
Asenapine—Constipation—Pregabalin—epilepsy syndrome	3.05e-05	0.000271	CcSEcCtD
Asenapine—Malaise—Topiramate—epilepsy syndrome	3.04e-05	0.00027	CcSEcCtD
Asenapine—Syncope—Topiramate—epilepsy syndrome	3.02e-05	0.000269	CcSEcCtD
Asenapine—Leukopenia—Topiramate—epilepsy syndrome	3.02e-05	0.000268	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.98e-05	0.000265	CcSEcCtD
Asenapine—Loss of consciousness—Topiramate—epilepsy syndrome	2.96e-05	0.000263	CcSEcCtD
Asenapine—Insomnia—Gabapentin—epilepsy syndrome	2.96e-05	0.000263	CcSEcCtD
Asenapine—Nausea—Lamotrigine—epilepsy syndrome	2.95e-05	0.000262	CcSEcCtD
Asenapine—Convulsion—Topiramate—epilepsy syndrome	2.92e-05	0.00026	CcSEcCtD
Asenapine—Dyspnoea—Gabapentin—epilepsy syndrome	2.91e-05	0.000259	CcSEcCtD
Asenapine—Hypertension—Topiramate—epilepsy syndrome	2.91e-05	0.000259	CcSEcCtD
Asenapine—Somnolence—Gabapentin—epilepsy syndrome	2.91e-05	0.000259	CcSEcCtD
Asenapine—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.91e-05	0.000258	CcSEcCtD
Asenapine—Dyspepsia—Gabapentin—epilepsy syndrome	2.88e-05	0.000256	CcSEcCtD
Asenapine—Arthralgia—Topiramate—epilepsy syndrome	2.87e-05	0.000255	CcSEcCtD
Asenapine—Anxiety—Topiramate—epilepsy syndrome	2.86e-05	0.000254	CcSEcCtD
Asenapine—Asthenia—Valproic Acid—epilepsy syndrome	2.83e-05	0.000252	CcSEcCtD
Asenapine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.82e-05	0.000251	CcSEcCtD
Asenapine—Fatigue—Gabapentin—epilepsy syndrome	2.82e-05	0.000251	CcSEcCtD
Asenapine—Dry mouth—Topiramate—epilepsy syndrome	2.81e-05	0.00025	CcSEcCtD
Asenapine—Constipation—Gabapentin—epilepsy syndrome	2.8e-05	0.000249	CcSEcCtD
Asenapine—Shock—Topiramate—epilepsy syndrome	2.71e-05	0.000241	CcSEcCtD
Asenapine—Nervous system disorder—Topiramate—epilepsy syndrome	2.7e-05	0.00024	CcSEcCtD
Asenapine—Thrombocytopenia—Topiramate—epilepsy syndrome	2.69e-05	0.00024	CcSEcCtD
Asenapine—Tachycardia—Topiramate—epilepsy syndrome	2.68e-05	0.000239	CcSEcCtD
Asenapine—Hypersensitivity—Pregabalin—epilepsy syndrome	2.63e-05	0.000234	CcSEcCtD
Asenapine—Dizziness—Valproic Acid—epilepsy syndrome	2.61e-05	0.000232	CcSEcCtD
Asenapine—Hypotension—Topiramate—epilepsy syndrome	2.57e-05	0.000229	CcSEcCtD
Asenapine—Asthenia—Pregabalin—epilepsy syndrome	2.56e-05	0.000228	CcSEcCtD
Asenapine—Vomiting—Valproic Acid—epilepsy syndrome	2.51e-05	0.000223	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.51e-05	0.000223	CcSEcCtD
Asenapine—Insomnia—Topiramate—epilepsy syndrome	2.49e-05	0.000221	CcSEcCtD
Asenapine—Rash—Valproic Acid—epilepsy syndrome	2.49e-05	0.000221	CcSEcCtD
Asenapine—Dermatitis—Valproic Acid—epilepsy syndrome	2.48e-05	0.000221	CcSEcCtD
Asenapine—Headache—Valproic Acid—epilepsy syndrome	2.47e-05	0.00022	CcSEcCtD
Asenapine—Dyspnoea—Topiramate—epilepsy syndrome	2.45e-05	0.000218	CcSEcCtD
Asenapine—Somnolence—Topiramate—epilepsy syndrome	2.45e-05	0.000217	CcSEcCtD
Asenapine—Dyspepsia—Topiramate—epilepsy syndrome	2.42e-05	0.000215	CcSEcCtD
Asenapine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.41e-05	0.000214	CcSEcCtD
Asenapine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.37e-05	0.000211	CcSEcCtD
Asenapine—Fatigue—Topiramate—epilepsy syndrome	2.37e-05	0.000211	CcSEcCtD
Asenapine—Dizziness—Pregabalin—epilepsy syndrome	2.36e-05	0.00021	CcSEcCtD
Asenapine—Constipation—Topiramate—epilepsy syndrome	2.35e-05	0.000209	CcSEcCtD
Asenapine—Asthenia—Gabapentin—epilepsy syndrome	2.35e-05	0.000209	CcSEcCtD
Asenapine—Nausea—Valproic Acid—epilepsy syndrome	2.34e-05	0.000208	CcSEcCtD
Asenapine—Vomiting—Pregabalin—epilepsy syndrome	2.27e-05	0.000202	CcSEcCtD
Asenapine—Rash—Pregabalin—epilepsy syndrome	2.25e-05	0.0002	CcSEcCtD
Asenapine—Dermatitis—Pregabalin—epilepsy syndrome	2.25e-05	0.0002	CcSEcCtD
Asenapine—Headache—Pregabalin—epilepsy syndrome	2.23e-05	0.000199	CcSEcCtD
Asenapine—Dizziness—Gabapentin—epilepsy syndrome	2.16e-05	0.000192	CcSEcCtD
Asenapine—Nausea—Pregabalin—epilepsy syndrome	2.12e-05	0.000188	CcSEcCtD
Asenapine—Vomiting—Gabapentin—epilepsy syndrome	2.08e-05	0.000185	CcSEcCtD
Asenapine—Rash—Gabapentin—epilepsy syndrome	2.06e-05	0.000183	CcSEcCtD
Asenapine—Dermatitis—Gabapentin—epilepsy syndrome	2.06e-05	0.000183	CcSEcCtD
Asenapine—Headache—Gabapentin—epilepsy syndrome	2.05e-05	0.000182	CcSEcCtD
Asenapine—Hypersensitivity—Topiramate—epilepsy syndrome	2.03e-05	0.00018	CcSEcCtD
Asenapine—Asthenia—Topiramate—epilepsy syndrome	1.97e-05	0.000176	CcSEcCtD
Asenapine—Nausea—Gabapentin—epilepsy syndrome	1.94e-05	0.000173	CcSEcCtD
Asenapine—Dizziness—Topiramate—epilepsy syndrome	1.82e-05	0.000162	CcSEcCtD
Asenapine—Vomiting—Topiramate—epilepsy syndrome	1.75e-05	0.000156	CcSEcCtD
Asenapine—Rash—Topiramate—epilepsy syndrome	1.73e-05	0.000154	CcSEcCtD
Asenapine—Dermatitis—Topiramate—epilepsy syndrome	1.73e-05	0.000154	CcSEcCtD
Asenapine—Headache—Topiramate—epilepsy syndrome	1.72e-05	0.000153	CcSEcCtD
Asenapine—Nausea—Topiramate—epilepsy syndrome	1.63e-05	0.000145	CcSEcCtD
Asenapine—DRD1—Signaling Pathways—RELA—epilepsy syndrome	7.22e-07	8.25e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	7.17e-07	8.19e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	7.17e-07	8.18e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	7.16e-07	8.18e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	7.16e-07	8.18e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	7.15e-07	8.17e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	7.14e-07	8.16e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	7.14e-07	8.16e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	7.14e-07	8.16e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—TH—epilepsy syndrome	7.14e-07	8.16e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	7.13e-07	8.14e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—RELA—epilepsy syndrome	7.12e-07	8.14e-06	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—POMC—epilepsy syndrome	7.11e-07	8.12e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	7.1e-07	8.1e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	7.08e-07	8.09e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.07e-07	8.08e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	7.07e-07	8.08e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	7.06e-07	8.07e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	7.03e-07	8.03e-06	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	7.03e-07	8.03e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.03e-07	8.03e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—JUN—epilepsy syndrome	7.03e-07	8.03e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	7.02e-07	8.02e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	7e-07	7.99e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	6.99e-07	7.99e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	6.99e-07	7.98e-06	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	6.98e-07	7.97e-06	CbGpPWpGaD
Asenapine—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	6.97e-07	7.96e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	6.95e-07	7.93e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CAT—epilepsy syndrome	6.94e-07	7.93e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	6.93e-07	7.92e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	6.93e-07	7.91e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	6.93e-07	7.91e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	6.92e-07	7.9e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	6.91e-07	7.89e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.89e-07	7.87e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	6.88e-07	7.86e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.85e-07	7.82e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	6.84e-07	7.81e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	6.84e-07	7.81e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	6.78e-07	7.74e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	6.75e-07	7.71e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	6.74e-07	7.7e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	6.71e-07	7.66e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	6.69e-07	7.64e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	6.65e-07	7.6e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	6.64e-07	7.59e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	6.63e-07	7.57e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—SRC—epilepsy syndrome	6.59e-07	7.53e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—SRC—epilepsy syndrome	6.58e-07	7.52e-06	CbGpPWpGaD
Asenapine—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.57e-07	7.51e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	6.54e-07	7.47e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	6.53e-07	7.46e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	6.53e-07	7.45e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	6.53e-07	7.45e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	6.52e-07	7.45e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	6.51e-07	7.44e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	6.5e-07	7.42e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	6.5e-07	7.42e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	6.49e-07	7.41e-06	CbGpPWpGaD
Asenapine—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	6.49e-07	7.41e-06	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—ALB—epilepsy syndrome	6.48e-07	7.4e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	6.47e-07	7.39e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	6.43e-07	7.35e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	6.43e-07	7.34e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	6.42e-07	7.33e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	6.41e-07	7.32e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	6.41e-07	7.32e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	6.4e-07	7.31e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	6.39e-07	7.3e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	6.38e-07	7.29e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	6.37e-07	7.28e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	6.37e-07	7.27e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	6.35e-07	7.25e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	6.33e-07	7.23e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—JUN—epilepsy syndrome	6.33e-07	7.23e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	6.31e-07	7.2e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—SRC—epilepsy syndrome	6.3e-07	7.2e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	6.28e-07	7.17e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	6.26e-07	7.15e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—JUN—epilepsy syndrome	6.24e-07	7.13e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	6.24e-07	7.13e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	6.23e-07	7.11e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	6.21e-07	7.09e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.18e-07	7.06e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	6.18e-07	7.06e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	6.15e-07	7.03e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	6.14e-07	7.01e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	6.09e-07	6.95e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	6.07e-07	6.94e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	6.06e-07	6.92e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	6.02e-07	6.87e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	6.01e-07	6.86e-06	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—AKT1—epilepsy syndrome	6e-07	6.85e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	5.97e-07	6.82e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	5.96e-07	6.81e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	5.94e-07	6.79e-06	CbGpPWpGaD
Asenapine—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.91e-07	6.75e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	5.89e-07	6.73e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	5.89e-07	6.73e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.89e-07	6.72e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CAT—epilepsy syndrome	5.88e-07	6.72e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	5.87e-07	6.71e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.86e-07	6.69e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	5.86e-07	6.69e-06	CbGpPWpGaD
Asenapine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	5.86e-07	6.69e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	5.85e-07	6.69e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	5.82e-07	6.64e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	5.8e-07	6.63e-06	CbGpPWpGaD
Asenapine—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.78e-07	6.6e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	5.78e-07	6.6e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	5.77e-07	6.59e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	5.73e-07	6.54e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	5.72e-07	6.53e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	5.69e-07	6.5e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—SRC—epilepsy syndrome	5.67e-07	6.48e-06	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	5.67e-07	6.48e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	5.66e-07	6.46e-06	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	5.65e-07	6.46e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	5.63e-07	6.44e-06	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	5.62e-07	6.42e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	5.6e-07	6.4e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—SRC—epilepsy syndrome	5.6e-07	6.39e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.59e-07	6.39e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	5.57e-07	6.36e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	5.56e-07	6.35e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	5.53e-07	6.32e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.53e-07	6.32e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	5.53e-07	6.31e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—TH—epilepsy syndrome	5.51e-07	6.29e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.5e-07	6.29e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	5.48e-07	6.26e-06	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	5.47e-07	6.25e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	5.45e-07	6.23e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	5.45e-07	6.23e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	5.44e-07	6.21e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	5.42e-07	6.19e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	5.41e-07	6.18e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	5.41e-07	6.18e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.39e-07	6.16e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	5.37e-07	6.13e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	5.36e-07	6.13e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	5.35e-07	6.11e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	5.35e-07	6.11e-06	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—AKT1—epilepsy syndrome	5.34e-07	6.1e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	5.32e-07	6.07e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	5.32e-07	6.07e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	5.29e-07	6.04e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	5.27e-07	6.01e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	5.26e-07	6.01e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	5.26e-07	6.01e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	5.26e-07	6e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	5.25e-07	6e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	5.25e-07	6e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	5.25e-07	6e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	5.15e-07	5.88e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	5.13e-07	5.86e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	5.12e-07	5.85e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	5.11e-07	5.83e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	5.1e-07	5.83e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	5.05e-07	5.77e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	4.99e-07	5.7e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	4.97e-07	5.67e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	4.97e-07	5.67e-06	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.96e-07	5.67e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	4.92e-07	5.62e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	4.92e-07	5.62e-06	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.88e-07	5.58e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	4.88e-07	5.57e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	4.88e-07	5.57e-06	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.87e-07	5.57e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	4.86e-07	5.55e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	4.85e-07	5.54e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	4.84e-07	5.53e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	4.83e-07	5.51e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	4.79e-07	5.47e-06	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.78e-07	5.46e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	4.78e-07	5.45e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	4.75e-07	5.43e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	4.74e-07	5.41e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	4.73e-07	5.4e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	4.72e-07	5.39e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	4.7e-07	5.37e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	4.69e-07	5.36e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AGT—epilepsy syndrome	4.66e-07	5.33e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	4.65e-07	5.31e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.63e-07	5.29e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	4.6e-07	5.26e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.6e-07	5.25e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	4.6e-07	5.25e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	4.57e-07	5.22e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.57e-07	5.22e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	4.56e-07	5.21e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.54e-07	5.18e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	4.51e-07	5.15e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	4.48e-07	5.11e-06	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	4.44e-07	5.07e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	4.43e-07	5.06e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	4.42e-07	5.05e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.41e-07	5.04e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	4.4e-07	5.03e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	4.34e-07	4.96e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	4.28e-07	4.89e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	4.28e-07	4.88e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.22e-07	4.82e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	4.22e-07	4.81e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	4.21e-07	4.8e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	4.17e-07	4.77e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	4.16e-07	4.75e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	4.13e-07	4.71e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	4.11e-07	4.69e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.1e-07	4.69e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	4.1e-07	4.68e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	4.1e-07	4.68e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	4.09e-07	4.67e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	4.07e-07	4.64e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	4.03e-07	4.61e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	4.02e-07	4.59e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	3.98e-07	4.55e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—POMC—epilepsy syndrome	3.92e-07	4.48e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	3.92e-07	4.47e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	3.83e-07	4.38e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	3.74e-07	4.27e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	3.74e-07	4.27e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.7e-07	4.22e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.6e-07	4.11e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.58e-07	4.09e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	3.53e-07	4.03e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.53e-07	4.03e-06	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	3.51e-07	4.01e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	3.48e-07	3.97e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	3.17e-07	3.62e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	3.14e-07	3.59e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.13e-07	3.58e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	3.1e-07	3.54e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	3.03e-07	3.46e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.03e-07	3.46e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	3.02e-07	3.45e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	2.93e-07	3.35e-06	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	2.85e-07	3.26e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.76e-07	3.15e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	2.66e-07	3.04e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	2.62e-07	2.99e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	2.61e-07	2.99e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	2.56e-07	2.93e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.42e-07	2.76e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	2.38e-07	2.72e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.86e-07	2.12e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.57e-07	1.8e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.21e-07	1.39e-06	CbGpPWpGaD
